1. Introduction

The Biometric Fertility Doctrine of Accountability and Governance is a proposed legal and regulatory framework for examining how biometric technologies, reproductive-health data, and fertility-related algorithms should be collected, processed, monitored, and controlled.

It is not, as of this discussion, a formally established doctrine bearing this exact name in Indian law. Rather, it is a useful analytical framework developed from established legal principles concerning privacy, bodily autonomy, reproductive freedom, informed consent, equality, data protection, and institutional accountability.

The framework becomes relevant when biometric or biometric-linked technologies are used in connection with:

Fertility assessment and reproductive-health screening.

Assisted reproductive technology (ART), IVF, and fertility clinics.

Fingerprint, facial, or other biometric authentication for fertility services.

Digital fertility tracking and reproductive-health applications.

Genetic and biological identification in reproductive medicine.

Employer or insurer surveillance of fertility-related information.

Automated systems that classify people according to fertility status or reproductive risk.

The central legal question is:

How can institutions use technology for legitimate reproductive-health purposes without undermining an individual's privacy, dignity, reproductive autonomy, or freedom from discrimination?

In India, this question must be examined through constitutional law, the Digital Personal Data Protection Act, 2023, applicable rules and commencement notifications, the Aadhaar framework where relevant, medical and ART regulation, and judicial precedents.

2. Meaning and scope of the doctrine

The proposed framework has three interconnected elements.

A. Biometric fertility

The use of biometric identifiers or biometric-linked information in fertility-related services. Ordinary biometric identifiers, such as fingerprints, must be distinguished from reproductive biomarkers, hormone measurements, genetic information, and menstrual-cycle data. These are not all legally the same category of information.

B. Accountability

The duty of clinics, technology companies, laboratories, employers, insurers, and public authorities to justify their practices, maintain appropriate safeguards, explain consequential decisions, and provide remedies for unlawful or harmful conduct.

C. Governance

The laws, institutional procedures, technical standards, audits, consent mechanisms, and oversight arrangements that regulate the collection and use of reproductive and biometric information.

The doctrine therefore concerns not simply whether a technology works, but whether its use is lawful, necessary, proportionate, scientifically defensible, and accountable to the people affected by it.

3. Constitutional foundation in India

A. Article 21: Privacy, dignity, and bodily autonomy

Article 21 of the Constitution protects life and personal liberty. The Supreme Court has interpreted this protection to encompass privacy, dignity, and important decisions concerning one's body and personal life.

The leading authority is Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1. A nine-judge bench recognized privacy as a fundamental right under the Constitution. The judgment is particularly relevant because it addresses informational privacy, bodily autonomy, and the individual's ability to make intimate personal decisions.

PRIVACY+1

Applied to fertility technology, these principles support the following propositions:

Reproductive-health information may reveal intimate aspects of a person's life.

Collecting such information can interfere with privacy even when no information is publicly disclosed.

A person's decision to pursue, postpone, or decline fertility treatment deserves protection against unjustified interference.

Institutions should not assume that consent to one medical service authorizes every additional use of the person's data.

For example, a fertility clinic may legitimately need information relevant to an IVF procedure. That does not automatically justify sharing a patient's reproductive information with an employer, an advertising company, or an unrelated commercial database.

B. Articles 14 and 15: Equality and non-discrimination

Article 14 guarantees equality before the law and equal protection of the laws. Article 15 prohibits specified forms of discrimination by the State, including discrimination on grounds of sex, subject to the constitutional text and applicable interpretation.

A fertility-scoring system could raise equality concerns if it systematically disadvantages women, people with disabilities, unmarried people, or other groups through inaccurate assumptions, inappropriate criteria, or discriminatory institutional policies.

The legal analysis must distinguish between:

A clinically justified medical assessment.

A statistically unreliable prediction presented as a medical fact.

An administrative classification that denies access to a service.

A discriminatory employment, insurance, or public-benefit decision.

Not every adverse outcome amounts to a constitutional violation. The legal claim depends on the actor involved, the applicable law, the evidence, and the nature of the discrimination.

C. Reproductive autonomy

Reproductive autonomy includes decisions about whether and when to have children, subject to the relevant legal framework.

In X v. Principal Secretary, Health and Family Welfare Department, Government of NCT of Delhi, (2023) 9 SCC 433, arising from the 2022 judgment, the Supreme Court discussed reproductive autonomy as closely connected with bodily and decisional autonomy. The Court recognized the importance of a pregnant person's decision-making authority in the context of abortion law.

Sci API

Although this case did not concern biometric fertility technology, its reasoning is relevant to a governance framework that seeks to prevent technology from becoming a mechanism for coercive reproductive decision-making.

For instance, an algorithmic fertility prediction should not, by itself, determine whether a person may marry, access ordinary employment, receive an unrelated public benefit, or make a reproductive decision.

4. Statutory framework governing biometric fertility data

A. Assisted Reproductive Technology (Regulation) Act, 2021

The most directly relevant Indian legislation is the Assisted Reproductive Technology (Regulation) Act, 2021. It regulates ART clinics and banks, treatment procedures, donor-related practices, recordkeeping, and confidentiality.

India Code+1

Three provisions are particularly significant.

Section 21 — General duties of clinics and banks

Clinics must provide professional counselling, explain treatment implications and risks, protect the confidentiality of patients and donors, maintain grievance mechanisms, and comply with applicable registration and recordkeeping requirements. The Act permits specified disclosures, including information supplied to the National Registry, certain medical emergencies, and court-authorized disclosures.

IndiaCode+1

Section 22 — Written informed consent

ART treatment requires written informed consent from the relevant parties. The provision also addresses consent for cryopreservation and use of reproductive material, including withdrawal of consent before transfer of embryos or gametes to the woman's uterus, subject to the statutory terms.

IndiaCode+1

Section 23 — Accurate records

Clinics and banks have statutory duties concerning the maintenance of accurate records. These obligations are important where electronic systems are used to identify patients, match samples, track embryos, or record treatment outcomes.

The implications for biometric governance are substantial. A clinic should not confuse consent to medical treatment with unlimited permission to collect facial scans, use fingerprint authentication for unrelated purposes, or share fertility profiles with third parties.

The Act does not establish a comprehensive, separate statutory code specifically for biometric fertility systems. Its existing duties must therefore be applied alongside other applicable laws.

B. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 establishes a framework for the processing of digital personal data, including obligations concerning lawful processing, consent where applicable, security, individual rights, and accountability.

The Digital Personal Data Protection Rules, 2025 were notified in November 2025. However, commencement is phased: not all substantive obligations became operative upon notification. As of 28 October 2026, the principal processing provisions are scheduled to commence 18 months after the November 2025 notification, in May 2027. Accordingly, their actual commencement must be checked before asserting that a particular obligation is already enforceable.

Press Information Bureau+2

For fertility-related data, the important governance principles include:

Purpose limitation: Information should be used for a lawful, specified purpose rather than repurposed without an appropriate legal basis.

Data minimisation: Collect only the information reasonably needed for the relevant function.

Security: Protect information against unauthorized access, disclosure, alteration, or loss.

Transparency: Explain what data is collected, why it is needed, and how it is used.

Accountability: Identify who is responsible for the processing and establish appropriate procedures for complaints and compliance.

An important qualification is that the DPDP Act does not create a separate general category of “biometric fertility data” with the same structure as the former sensitive-personal-data categories under India's Information Technology Rules. Its scope and provisions must be assessed according to the actual information and processing involved.

C. Aadhaar Act, 2016

Where a fertility clinic or related institution uses Aadhaar authentication, the Aadhaar Act may become relevant.

Sections 29 and 30 address restrictions on the use and disclosure of identity information and the treatment of biometric information. The statutory restrictions must be considered alongside the constitutional principles established in the Aadhaar litigation.

National Digital Library of India+1

A critical distinction is that Aadhaar authentication is not proof of fertility, infertility, parentage, or medical fitness. Authentication establishes identity for the authorized purpose; it does not independently establish a medical conclusion.

A clinic should therefore avoid treating successful biometric authentication as proof that a patient's medical record, reproductive status, or genetic sample has been correctly matched without additional appropriate verification.

5. Detailed explanation of accountability principles

The proposed doctrine can be organized into six principles.

Principle 1: Legality and legitimate purpose

An institution must identify the legal basis for collecting or processing biometric and reproductive data. Convenience, commercial value, or technological availability alone does not justify intrusive collection.

Example: A fertility clinic should explain why fingerprint verification is necessary if a less intrusive patient-identification procedure would achieve the same purpose.

Principle 2: Meaningful and specific consent

Consent should be informed, voluntary where required, and sufficiently clear about the proposed use. Medical consent, biometric authentication, research participation, and commercial data sharing are different decisions.

Example: Agreeing to IVF does not automatically authorize a technology provider to use the patient's fertility information to train an unrelated commercial prediction model.

Principle 3: Data minimisation and security

Institutions should restrict access, encrypt information where appropriate, maintain access logs, separate identifying details from research datasets where feasible, and define retention and deletion procedures.

Example: A laboratory may need a coded identifier to track an embryo sample, but many staff members do not need access to the patient's entire reproductive history.

Principle 4: Scientific validity and algorithmic accountability

Fertility-related predictions should be clinically appropriate, validated for their intended use, and communicated with their limitations. A correlation or probabilistic estimate must not be presented as certainty.

Example: An automated system estimating ovarian response should not be represented as a definitive prediction of whether someone can conceive naturally.

Principle 5: Equality and freedom from coercion

Fertility data should not be used to impose unjustified reproductive expectations or to make unrelated decisions about employment, education, insurance, or public benefits.

Example: A workplace should not use a fertility prediction to pressure an employee to disclose pregnancy plans or to penalize an employee for seeking fertility treatment.

Principle 6: Independent oversight and remedies

Institutions should maintain complaint mechanisms, investigate incidents, preserve relevant records, correct errors, and provide access to appropriate regulatory or judicial remedies.

Example: If a biometric mismatch causes a patient to receive the wrong medical record or delays time-sensitive treatment, the clinic should investigate the failure rather than automatically attributing it to the patient.

These principles are a proposed synthesis of existing legal requirements and constitutional values, not six independently enacted statutory rules.

6. Leading case laws and their application

The following judgments do not all concern biometric fertility systems directly. They supply legal principles from which the proposed accountability framework can be developed.

Case 1. Justice K.S. Puttaswamy (Retd.) v. Union of India

Citation: (2017) 10 SCC 1; Supreme Court of India.

Facts and issue: The Court considered whether privacy is protected as a fundamental right under the Constitution, in litigation connected with the Aadhaar programme and the collection of personal information.

Held: The nine-judge bench unanimously recognized privacy as a constitutionally protected right. The judgment linked privacy to dignity, autonomy, and control over important personal decisions.

PRIVACY+1

Application to biometric fertility governance: A system that collects biometric identifiers together with menstrual-cycle records, fertility assessments, or reproductive treatment histories may create an unusually revealing personal profile.

The judgment supports scrutiny of the purpose, scope, and safeguards of such collection. Governmental interference with privacy must satisfy the applicable constitutional requirements, including legality, legitimate aim, and proportionality.

Legal significance: This is the principal constitutional foundation for examining the collection and use of biometric fertility information in India.

Case 2. K.S. Puttaswamy (Retd.) v. Union of India — Aadhaar judgment

Citation: (2019) 1 SCC 1; Supreme Court of India, judgment delivered on 26 September 2018.

Facts and issue: The Court examined the constitutional validity of the Aadhaar framework, including biometric identification, data use, and safeguards.

Held: The majority upheld the Aadhaar Act's core framework while limiting certain uses and emphasizing statutory safeguards. The opinions differed on aspects of the scheme. The judgment should not be understood as an unrestricted authorization for every form of biometric processing.

Indian Kanoon+1

Application: A fertility provider cannot assume that because a biometric identification system is lawful in one regulated context, it is automatically lawful for all medical or commercial purposes.

A separate analysis is needed for the specific purpose, the information processed, the legal authority, and the consequences of misuse.

Legal significance: The case illustrates why biometric governance must combine authorization with purpose restrictions, safeguards, and proportionality.

Case 3. Suchita Srivastava v. Chandigarh Administration

Citation: (2009) 9 SCC 1; Supreme Court of India.

Facts and issue: The case concerned the reproductive autonomy of a woman with an intellectual disability and whether a pregnancy could be terminated without her consent under the circumstances.

Held: The Supreme Court recognized that reproductive choices, including the choice to procreate or abstain from procreation, fall within personal liberty under Article 21. The judgment emphasized the importance of consent and bodily integrity in reproductive decision-making.

Indian Kanoon+1

Application: A biometric fertility system must not become a substitute for an individual's legally required consent. Nor should a prediction produced by an algorithm, standing alone, authorize a reproductive procedure or dictate a person's reproductive choices.

Legal significance: This case provides a direct constitutional link between reproductive autonomy and consent, making it one of the most important precedents for the proposed doctrine.

Case 4. X v. Principal Secretary, Health and Family Welfare Department, Government of NCT of Delhi

Citation: (2023) 9 SCC 433; Supreme Court of India.

Facts and issue: The case examined access to abortion under the Medical Termination of Pregnancy framework, including the position of unmarried women.

Held: The Court interpreted the statutory framework in a manner that recognized reproductive autonomy and rejected an unjustifiably narrow understanding of women's access to reproductive healthcare. The Court also explained the relationship between bodily autonomy, decisional autonomy, and privacy.

Sci API+1

Application: Fertility-related classifications should not impose unjustified assumptions about marital status or the legitimacy of a person's reproductive choices. Digital systems should support informed medical decisions rather than dictate them.

Legal significance: The judgment supports an autonomy-centred approach to reproductive healthcare and cautions against discriminatory assumptions embedded in institutional practices.

Case 5. Justice K.S. Puttaswamy (Retd.) v. Union of India — reproductive autonomy principles

The privacy opinions in the 2017 Puttaswamy judgment also treated reproductive choices as part of the protected sphere of personal decision-making.

Indian Kanoon+1

The relevant principle is broader than confidentiality: a person may have a legally protected interest in deciding how intimate information is used, not merely in preventing strangers from seeing it.

For fertility technology, this supports a distinction between:

Collecting information for a patient's requested medical care.

Reusing the information for research under an appropriate legal and ethical framework.

Transferring it to a third party for commercial profiling.

Using it to make decisions unrelated to medical treatment.

Each use requires its own legal assessment. The original clinical purpose cannot automatically justify all subsequent processing.

Case 6. S. and Marper v. United Kingdom

Citation: Applications Nos. 30562/04 and 30566/04, European Court of Human Rights, Grand Chamber, 4 December 2008.

Facts and issue: The case concerned the retention of fingerprints, cellular samples, and DNA profiles of people who had not been convicted of the offences associated with their records.

Held: The European Court of Human Rights found that the blanket retention regime violated Article 8 of the European Convention on Human Rights, which protects private and family life. It emphasized the sensitive nature of biological information and the privacy implications of retaining it.

Indian Kanoon+1

Application: A fertility laboratory or reproductive-health platform should not retain identifying biological material and related data indefinitely simply because retention is technically possible.

Retention should be justified by the applicable law, clinical needs, legitimate recordkeeping requirements, and any valid consent or research arrangements.

Legal significance: This is a persuasive comparative authority, not binding Indian precedent. It helps explain why retention and reuse of biological information require independent scrutiny.

Case 7. Skinner v. Oklahoma ex rel. Williamson

Citation: 316 U.S. 535 (1942); Supreme Court of the United States.

Facts and issue: The case challenged a state law authorizing compulsory sterilization of certain repeat offenders.

Held: The US Supreme Court invalidated the challenged sterilization regime under the Equal Protection Clause, emphasizing the fundamental significance of procreation and the unequal treatment produced by the law.

Application: The case is relevant by analogy when a state or institution seeks to use biological classification to control reproductive opportunities or impose unequal reproductive consequences.

Legal significance: This is a comparative US constitutional authority. It does not directly establish Indian rules governing fertility biometrics, but it highlights the danger of allowing state classification systems to determine who may reproduce.

7. Liability and accountability for misuse

The proposed doctrine requires responsibility to be allocated according to the role played by each institution.

These are potential grounds of responsibility, not automatic findings of liability. The applicable statutory provisions, evidence, causation, and available remedies must be examined in each case.

A. Negligence and medical liability

Suppose a clinic uses biometric identification to connect a patient with an IVF record but fails to verify a mismatch before a procedure.

The legal investigation should consider:

Whether the clinic followed reasonable professional and technical safeguards.

Whether the error caused injury or another legally recognizable harm.

Whether the clinic breached a statutory, professional, or contractual duty.

Whether the technology provider contributed to the failure.

What corrective measures and remedies are available.

The use of advanced technology does not automatically relieve a healthcare provider of its ordinary professional responsibilities.

B. Confidentiality and unauthorized disclosure

Section 21 of the ART Act expressly requires confidentiality of information relating to the commissioning couple, woman, and gamete donor, subject to specified exceptions. A disclosure outside the permitted framework may therefore raise statutory and other legal issues.

Indian Kanoon+1

For example, sharing an identifiable patient's IVF history with an advertising company without an appropriate legal basis may implicate confidentiality, privacy, contractual duties, and applicable data-protection law.

C. Algorithmic discrimination

Suppose a private employer purchases access to a fertility prediction system and uses the results to exclude applicants from recruitment.

Potential legal issues include the legitimacy of obtaining the information, privacy, consent, contractual or employment duties, and any applicable anti-discrimination protections. Where the State is involved, constitutional scrutiny may also arise.

The fact that an algorithm produces a score does not make the resulting decision legally neutral. Institutions should be able to identify the criteria used, test whether the system is reliable, and explain consequential decisions.

8. Practical governance model for fertility institutions

A legally responsible fertility institution can implement the proposed framework through the following process.

Biometric fertility governance checklist

Use this list to assess institutional readiness.

0/10

Identify the specific legal basis and purpose for collecting biometric and reproductive information.

Obtain the legally required medical consent and provide a clear explanation of biometric processing.

Separate clinical consent from optional research, marketing, and other secondary uses.

Restrict access to authorized staff and maintain appropriate access logs.

Verify patient identity and biological sample identity through suitable safeguards.

Validate any algorithm used to assess fertility or recommend treatment.

Review systems for inaccurate predictions and unjustified discriminatory outcomes.

Establish retention, deletion, incident-response, and data-sharing procedures.

Provide a clear complaint process and investigate errors promptly.

Review compliance with applicable ART, privacy, medical, and data-protection requirements.

This checklist is a governance aid, not a substitute for legal advice or a declaration that every item is independently mandated by statute.

9. Major legal challenges

Several unresolved questions are likely to become increasingly important as biometric and reproductive technologies develop.

First, the boundary between identification and biological inference. A fingerprint may establish identity, while a reproductive biomarker may support a clinical assessment. Combining them can create a much more sensitive profile than either dataset alone.

Second, consent in unequal relationships. A patient may feel compelled to accept intrusive data collection because a clinic, employer, or insurer controls access to something important. Whether consent is genuinely voluntary must be evaluated in context.

Third, accuracy and explainability. Fertility predictions are probabilistic and depend on clinical circumstances. Systems must distinguish risk estimation from diagnosis and avoid presenting uncertain outputs as conclusive facts.

Fourth, the rights of donors and children. ART systems process information relating to donors, intended parents, and children born through treatment. Confidentiality, recordkeeping, future access to information, and the applicable statutory requirements must be considered together.

Fifth, cross-border processing. International fertility services may transfer data between clinics, laboratories, cloud providers, and research institutions. The applicable Indian requirements and any additional jurisdictional obligations must be assessed separately.

Sixth, evolving data-protection legislation. India's DPDP framework has a phased commencement schedule. Institutions should distinguish provisions already in force from those scheduled to commence later rather than assuming that notification of the Rules made every substantive provision immediately operative.

IndiaCode+1

10. Conclusion

The Biometric Fertility Doctrine of Accountability and Governance is best understood as a proposed legal framework connecting biometric technology with reproductive autonomy, privacy, informed consent, scientific reliability, equality, confidentiality, and institutional responsibility.

Its principal legal foundations in India are:

Article 21 of the Constitution and the privacy judgment in K.S. Puttaswamy.

Reproductive autonomy as recognized in Suchita Srivastava and X v. Principal Secretary.

The statutory confidentiality, consent, and recordkeeping requirements of the Assisted Reproductive Technology (Regulation) Act, 2021.

The Aadhaar Act, where Aadhaar authentication is involved.

The Digital Personal Data Protection Act, 2023, and its applicable commencement notifications and Rules.

The comparative decisions in S. and Marper v. United Kingdom and Skinner v. Oklahoma further illustrate the importance of safeguarding biological information and preventing coercive reproductive classification.

The ultimate principle is that technology may assist reproductive healthcare, but it must not displace lawful consent, undermine reproductive autonomy, or become an unchecked mechanism for surveillance and discrimination.

The exact phrase used in this topic is not an independently established doctrine under Indian law. Its value lies in bringing established constitutional principles, legislation, case law, and responsible technological governance together into a coherent analytical framework.